Nirsevimab Starting Dose Guide — What to Expect & What It Costs
Just prescribed Nirsevimab? Here's what the typical starting dose looks like, how it changes over the first few weeks, what to expect from your body, and what to budget for your first fill at $253/month or less.
Always follow your prescriber's specific dosing instructions. Starting doses vary based on your individual health, age, weight, kidney function, and other medications. This is general guidance only — not medical advice.
Common Nirsevimab doses — from starting to maintenance
Nirsevimab is typically titrated through these standard strengths. Most adults start at the lowest available dose and increase under prescriber supervision:
| Strength | Stage | Cash price /mo |
|---|---|---|
| 50mg IM | Starting dose | $253+ |
| 100mg IM | Maximum dose | $589+ |
Cash prices via Script Unlock pharmacy bidding. Lower strengths typically cost less per month than higher strengths of the same Nirsevimab.
Why starting doses of Nirsevimab are lower than maintenance doses
Your prescriber didn't pick the starting dose at random. The titration approach — starting low and increasing gradually — is the safest, best-supported way to use Nirsevimab. Here's why:
- 1Your body adapts to the medicationMost Nirsevimab side effects (nausea, dizziness, GI upset, headache) are dose-dependent and peak in the first 1–2 weeks. Starting low gives your body time to acclimate before reaching the therapeutic dose.
- 2Your prescriber monitors response & tolerabilityStarting low lets your prescriber see how YOU respond to Nirsevimab — not how the average patient responds. They check blood work, blood pressure, or symptoms before deciding to increase.
- 3Minimum effective dose principleNot every patient needs the maximum Nirsevimab dose. Many patients respond fully at the starting dose, especially in the first 2–4 weeks. Titrating up only when needed minimises side effects and cost.
- 4Reduces the risk of adverse reactionsSevere reactions to Nirsevimab — though rare — are far less likely at a starting dose than at maintenance. If you have a sensitivity, it's much safer to discover it at a low dose.
- 5It costs you less while you assessThe starting dose is usually the cheapest dose of Nirsevimab. If you and your prescriber decide Nirsevimab isn't right after 2–4 weeks, you've spent the minimum amount before pivoting.
Starting dose cost vs maintenance dose cost
Cash price for Nirsevimab is roughly proportional to the strength dispensed. Most patients pay less for the first 1–2 months while they're still titrating:
Budgeting tip: if you're starting Nirsevimab, plan for the starting-dose cost in months 1–2, then expect a step up to maintenance. Script Unlock locks in the lowest cash price each month — no membership.
Starting Nirsevimab — what to expect, week by week
Get your first Nirsevimab fill — from $253
Upload your Nirsevimab prescription. Verified pharmacies bid in real time so you pay the lowest cash price — even on the lower starting dose.
Compare Nirsevimab Prices from $253Nirsevimab starting dose — FAQ
What is the typical starting dose of Nirsevimab?+
The typical adult starting dose of Nirsevimab is 50mg IM, with a usual maintenance dose of 100mg IM and a maximum of 100mg IM. Your prescriber will personalise this based on your age, weight, kidney and liver function, other medications, and the condition being treated.
Why are starting doses of Nirsevimab lower than maintenance doses?+
Starting doses of Nirsevimab are deliberately lower so your body can adapt and your prescriber can monitor for side effects. This process — called titration — reduces dose-related side effects and lets the prescriber identify the lowest effective dose for you.
How much does the Nirsevimab starting dose cost?+
Nirsevimab at the starting dose typically costs less than at maintenance dose because you're using less drug per day. Script Unlock cash prices for Nirsevimab start from approximately $253/month at the starting dose, rising to about $421/month at maintenance.
Can I take more than my Nirsevimab starting dose if it isn't working?+
No — do not increase your Nirsevimab dose without prescriber approval. The starting dose is a clinical benchmark, not a minimum. Many patients respond fully at starting dose. If you feel it isn't working after 2–4 weeks, contact your prescriber for an evaluation.
When will my prescriber increase my Nirsevimab dose?+
Most prescribers re-evaluate Nirsevimab at the 4–6 week mark after starting. If your symptoms aren't adequately controlled — and you've tolerated the starting dose — they'll typically titrate up by one step. Follow the schedule your prescriber gives you.